Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization
Tessa J.J. de Bitter(Radboud University Nijmegen), Rachel S. van der Post(Radboud University Nijmegen), Marjolijn J. L. Ligtenberg(Radboud University Nijmegen), Leonie I. Kroeze(Radboud University Nijmegen), Irıs D. Nagtegaal(Radboud University Nijmegen), Shannon van Vliet(Radboud University Nijmegen), Elisa Vink‐Börger(Radboud University Nijmegen), Daniel von Rhein(Radboud University Nijmegen), Philip R. de Reuver(Radboud University Nijmegen), Erik A. M. Jansen(Radboud University Nijmegen)
Cited by 20
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
|Nature Genetics|2008|818
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
Hereditary diffuse gastric cancer: updated clinical practice guidelines
|The Lancet Oncology|2020|493
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
|The Lancet Oncology|2010|293